BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4899503)

  • 21. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations].
    Tzavellas O; Finke J
    Wien Klin Wochenschr; 1970 Oct; 82(41):714-6. PubMed ID: 5529668
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of Viquidil on cerebral circulation. Studies using a scintillation camera-computer system].
    Hünermann B; Felix R; Wesener K; Winkler C
    Arzneimittelforschung; 1973 Aug; 23(8):1074-6. PubMed ID: 4801028
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis].
    Eninia GI; Smeltere ES; Godlevska MA; Logina IP
    Klin Med (Mosk); 1985 Sep; 63(9):45-8. PubMed ID: 4068626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical aspects on the therapy of cerebral sclerosis].
    Hoffmeister K
    Med Klin; 1967 Jun; 62(23):910-2. PubMed ID: 4970034
    [No Abstract]   [Full Text] [Related]  

  • 25. [Regional cerebral blood flow and its regulation in the initial stage of cerebral arteriosclerosis].
    Man'kovskiĭ NB; Mints AIa; Lizogub VG; Kim B
    Klin Med (Mosk); 1979 Sep; 57(9):35-9. PubMed ID: 40063
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
    Danilova IN; Neretin VIa; Nesterova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical tests, in psychiatry, of a modifier of cerebral circulation: 1035 M.D].
    Porot M; Couadau A; Petit G; Lajoinie J
    Ann Med Psychol (Paris); 1968 Mar; 1(3):442-7. PubMed ID: 5670017
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study.
    Enger E; Boyesen S
    Acta Med Scand Suppl; 1965; 438():1-61. PubMed ID: 5323519
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of pentetrazole on serum cholesterol level and on behavior of patients with cerebral arteriosclerosis].
    Merkus JW
    Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1634-8. PubMed ID: 4878453
    [No Abstract]   [Full Text] [Related]  

  • 30. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
    Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
    Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of chronic consequences of brain ischemia. Comparison between two drugs acting on brain circulation and metabolism.
    Passeri M
    Eur Neurol; 1978; 17 Suppl 1():150-8. PubMed ID: 381005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic experience with Stugeron.
    Abrányi I
    Ther Hung; 1973; 21(3-4):117-20. PubMed ID: 4806419
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies of the mechanism of action of hypotensive agents on cerebral circulation. Therapeutic experiment with Brinderdine (DCR 515 Sandoz)].
    Hărăguş S; Mureşan IG; Uza G
    Fiziol Norm Patol; 1970; 16(3):209-20. PubMed ID: 5429195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of cocarboxylase on cerebral circulation of patients with cerebral arteriosclerosis].
    Eninia GI; Smeltere ES
    Vrach Delo; 1974 Dec; (12):17-20. PubMed ID: 4446520
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydergine for cerebral arteriosclerosis.
    Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.